PINE BROOK, N.J.--(BUSINESS WIRE)--Alvogen, today announced that it has acquired five hormonal branded products from Bayer Pharma AG in Russia and CIS. The products acquired are Klimonorm (Hormone ...

PINEBROOK, N.J.--(BUSINESS WIRE)--A consortium of investors led by CVC Capital Partners (“CVC”) and including Singapore-based investment company Temasek (“Temasek”) and Vatera Healthcare Partners ...

LAKE FOREST, Ill., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (“Assertio” or “The Company”) (NASDAQ: ASRT), today announced the closing of its previously disclosed agreement ...

REYKJAVIK, Iceland and MORRISTOWN, N.J., March 10, 2025 (GLOBE NEWSWIRE) -- Alvogen Pharma US, Inc. (“Alvogen” or the “Company”), a privately owned US-based pharmaceutical company, has completed a ...